The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Total revenue | 55,534 | 53,316 | 163,664 |
| Policy commission and related expenses | 12,174 | 10,912 | 32,812 |
| Outsourced claims fees | 1,529 | 2,272 | 8,895 |
| Direct personnel expense | 4,984 | 1,957 | 15,165 |
| Other operating expenses | 3,534 | 2,716 | 8,816 |
| Depreciation and amortization | 570 | 585 | 1,827 |
| Gross profit | 32,743 | 34,874 | 96,149 |
| Personnel cost | 3,940 | 5,062 | 6,996 |
| Other operating expenses | 1,276 | 1,096 | 2,570 |
| Research and development | 2,306 | 1,761 | 7,069 |
| Depreciation and amortization | 146 | 141 | 338 |
| Total operating expenses | 7,668 | 8,060 | 16,973 |
| Operating income | 25,075 | 26,814 | 79,176 |
| Investment income | 2,512 | 2,039 | 2,263 |
| Interest expense | - | 0 | 0 |
| Income before income taxes | 27,587 | 28,853 | 81,439 |
| Income tax expense | 7,181 | 6,869 | 20,674 |
| Net income from continuing operations | - | 21,984 | 60,765 |
| Net income | 20,406 | - | - |
| Share-based compensation | 740 | 476 | 2,160 |
| Depreciation and amortization | 730 | 594 | 2,340 |
| Deferred income taxes | 191 | -2,962 | -2,134 |
| Net accretion of discount on investments in fixed-maturity securities | 4 | - | - |
| Foreign currency remeasurement losses (gains) | -96 | -32 | -141 |
| Accounts receivable | -393 | 2,906 | - |
| Receivable from related parties | - | -1,650 | 9,871 |
| Related party receivable and payable | 8,240 | - | - |
| Prepaid expenses | -290 | 359 | 515 |
| Contract cost assets | -152 | -837 | -2,852 |
| Income taxes | - | - | -4,531 |
| Income taxes payable | 6,939 | 5,554 | - |
| Contract liabilities | -156 | 2,665 | -21,549 |
| Commissions payable | 845 | -81 | 366 |
| Accounts payable and accrued liabilities | 3,281 | -9,078 | 9,512 |
| Other liabilities | 12 | 92 | -125 |
| Other assets | 525 | -1,867 | 1,868 |
| Operating lease | 10 | 45 | 46 |
| Cash provided by operating activities | 25,472 | 11,281 | 89,017 |
| Purchase of property and equipment | - | - | 2,441 |
| Capital expenditures | 327 | 2,844 | - |
| Cash used in investing activities | - | -403 | -2,441 |
| Redemption of redeemable preferred stock | - | 0 | 0 |
| Proceeds from issuance of notes payable, related party | - | 0 | 0 |
| Purchase of available-for-sale securities | 98,994 | - | - |
| Proceeds from initial public offering | - | 156,205 | - |
| Cash used in investing activities | -99,321 | - | - |
| Payment of issuance costs | 57 | 1,069 | - |
| Repurchase of common stock | - | 1,490 | 0 |
| Repayment of long-term debt | - | 0 | - |
| Dividends paid on redeemable preferred stock | - | 0 | 0 |
| Cash provided by (used in) financing activities | -57 | 153,646 | 0 |
| Effect of exchange rate changes on cash | -85 | -71 | -159 |
| Cash provided by (used in) continuing operations | - | 164,453 | 86,417 |
| Cash provided by operating activities from discontinued operations | - | 0 | 0 |
| Cash used in investing activities from discontinued operations | - | 0 | 0 |
| Cash (used in) provided by discontinued operations | - | 0 | 0 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | -73,991 | 164,453 | 86,417 |
| Cash and cash equivalents at beginning of period | - | - | 54,502 |
| Cash, cash equivalents, and restricted cash at beginning of period | 140,919 | - | - |
| Cash and cash equivalents at end of period | - | - | 140,919 |
| Cash, cash equivalents, and restricted cash at end of period | 231,381 | - | - |
Exzeo Group, Inc. (XZO)
Exzeo Group, Inc. (XZO)